Mobidiag

Activity by year

201820192020202120222023202420252026

PartnershipAcquisition

Apr 9, 2021ACQUISITION$795.0M
Hologic to acquire Mobidiag for $795M
Hologic has entered a definitive agreement to acquire Finnish-French molecular diagnostic test developer Mobidiag for an enterprise value of approximately $795 million, including $714 million in cash for equity and $81 million in net debt.
Hologic acquirer Mobidiag target #Medical Devices medicaldevice-network.com
Dec 18, 2018PARTNERSHIPChina, China$14.0M
Mobidiag and Autobio form joint venture for Novodiag platform in China
Mobidiag and Autobio Diagnostics formed a joint venture to commercialise the Novodiag platform in China, with a total investment of €12.3 million. Mobidiag holds 35% and Autobio 65%.
Mobidiag partner Autobio Diagnostics partner #Medical Devices medicaldevice-network.com

Acquired by

Partners

Loading…

Mobidiag: plants, expansions, contracts and acquisitions · Endata